A Diagnostic Cascade Triggered by Physical Examination: Uncovering Asymptomatic Left Ventricular Dysfunction and Critical Carotid Disease in a Hypertensive Patient
Abstract
Asymptomatic left ventricular systolic dysfunction (ALVSD) is a relatively uncommon condition. When left untreated, it carries the risk of progression to overt heart failure and adverse clinical outcomes. Here we present a case of a 60-year-old man with hypertension in whom severe left ventricular systolic dysfunction was identified in the absence of typical heart failure symptoms - uncovered through careful physical examination and directed diagnostic workup. The diagnostic process illustrates the value of thorough bedside assessment in revealing subclinical findings that might otherwise go undetected. Early recognition of severe left ventricular dysfunction at a pre-symptomatic stage allowed for the timely initiation of aggressive guideline-directed medical therapy (GDMT). Left ventricular ejection fraction improved from 30-35% to 44% within four months of treatment, and the patient remained free from heart failure hospitalization throughout the follow-up period. This case underscores the enduring importance of comprehensive physical examination - the most fundamental yet powerful tool available in clinical practice - in generating and refining the differential diagnosis. It also demonstrates how a carefully performed examination during a routine ambulatory encounter can profoundly alter the trajectory of patient care, particularly in resource-limited settings where access to advanced diagnostic testing may be constrained.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol
- Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance
- SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism
- Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors
- Sodium-glucose cotransporter inhibitors: beyond glycaemic control
- Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.